A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Clinical trial NCT05086666 · UNKNOWN
Trial details
- NCT number
- NCT05086666
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2023-08-14
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.